Loading clinical trials...
Loading clinical trials...
Assessing the Efficacy of Melatonin and Osteogenic Loading on Bone Health in an Osteopenic Population: MelaOstrong Study
Conditions
Interventions
Melatonin 5 mg
Osteogenic loading
+2 more
Locations
2
United States
OsteoStrong® in Scott Towne Center
Pittsburgh, Pennsylvania, United States
Duquesne University
Pittsburgh, Pennsylvania, United States
Start Date
May 26, 2020
Primary Completion Date
December 31, 2024
Completion Date
September 1, 2025
Last Updated
August 22, 2025
NCT07187518
NCT06988033
NCT06762730
NCT06551155
NCT06567054
NCT06888544
Lead Sponsor
Duquesne University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions